Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Abiomed Inc (NASDAQ:ABMD)

99.74
Delayed Data
As of May 27
 +0.94 / +0.95%
Today’s Change
59.04
Today|||52-Week Range
110.68
+10.48%
Year-to-Date

Today’s Trading

Previous close98.80
Today’s open98.81
Day’s range98.38 - 99.85
Volume321,165
Average volume (3 months)670,669
Market cap$4.3B
Dividend yield--
Data as of 4:00pm ET, 05/27/2016

Growth & Valuation

Earnings growth (last year)-67.92%
Earnings growth (this year)+32.81%
Earnings growth (next 5 years)+27.50%
Revenue growth (last year)+43.09%
P/E ratio35.4
Price/Sales12.92
Price/Book11.52

Competitors

 Today’s
change
Today’s
% change
DXCMDexCom Inc+2.14+3.39%
WSTWest Pharmaceutical ...+0.88+1.19%
IARTIntegra LifeSciences...+0.78+1.07%
NUVANuVasive Inc+1.64+3.08%
Data as of 4:02pm ET, 05/27/2016

Financials

Next reporting dateJuly 28, 2016
EPS forecast (this quarter)$0.23
Annual revenue (last year)$329.5M
Annual profit (last year)$38.1M
Net profit margin11.58%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Michael R. Minogue
Chief Operating Officer
David M. Weber
Corporate headquarters
Danvers, Massachusetts

Forecasts

Partner Offers

Search for Jobs